Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'c-Abl'

Search results for: 'c-Abl'

Items 11-20 of 72

Page
per page
  1. Masitinib (AB1010)
    A2942 Masitinib (AB1010)
    Target: PDGFR|c-Kit|Lyn
    Summary: Tyrosine kinase inhibitor, potent and selective
      ≥24.95 mg/mL
  2. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  3. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  4. Imatinib (STI571)
    B2171 Imatinib (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Protein-tyrosine kinase inhibitor
      ≥24.68 mg/mL
  5. PD173955
    A8812 PD173955
    Target: Bcr-Abl|Src
    Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,
      ≥22.15 mg/mL
  6. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  7. GW5074
    B1405 GW5074
    Summary: C-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥21.9 mg/mL
  8. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  9. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  10. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL

Items 11-20 of 72

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 68item
  2. Peptides 2item
  3. Peptides & Proteins 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. CXCR 1 item
  4. Raf 7item
  5. Aurora Kinases 4item
  6. mTOR 1 item
  7. Bromodomains 1 item
  8. AP-1 1 item
  9. MMP 1 item
  10. FLT3 5item
  11. Eph Receptors 2item
  12. VEGFR 14item
  13. PDGFR 11item
  14. c-Kit 6item
  15. RET 1 item
  16. Thymidylate Synthase 1 item
  17. Bcr-Abl 8item
  18. MEK 1 item
  19. FGFR 4item
  20. MET 5item
  21. Src 7item
  22. Trk Receptors 3item
  23. Microtubules/Tubulins 1 item
  24. EGFR 1 item
  25. FAK 1 item
  26. JAK 1 item
  27. DNA-PK 1 item
  28. AMPK 1 item
  29. Toll-like receptors (TLRs) 1 item
  30. c-MET 7item
  31. PKC 3item
  32. HCV Proteases 1 item
  33. Lyn 1 item
  34. HIV-1 gp120 1 item
  35. Tie-2 1 item
  36. Farnesyl Diphosphate Synthases 1 item
  37. Ron 1 item
  38. Synthases/Synthetases 1 item
  39. P110 1 item
  40. Hck 1 item
  41. ZAP-70 1 item
  42. c-Fms tyrosine kinase 1 item
  43. HCV polymerase 2item
  44. PC-PLC 1 item
  45. Lck 1 item
Reported Experiments
  1. Animal Experiments 63item
  2. Cell Experiments 44item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 2item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 10item
  7. Cancer 46item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 7item
  11. Colon Carcinoma 2item
  12. Colorectal Cancer 7item
  13. Glioblastoma 4item
  14. Glioma 1 item
  15. HCV 2item
  16. Hepatitis C 1 item
  17. Hepatocellular Carcinoma 1 item
  18. HIV 1 item
  19. Leukemia 3item
  20. Liver Cancer 1 item
  21. Lung Cancer 7item
  22. Lung Carcinoma 2item
  23. Lymphoma 2item
  24. Melanoma 5item
  25. Multiple Myeloma 2item
  26. Non-small Cell Lung Cancer 2item
  27. Ovarian Cancer 4item
  28. Pancreatic Cancer 7item
  29. Prostate Cancer 3item
  30. Renal Cancer 1 item
  31. Renal Cell Carcinoma 4item
  32. Rheumatoid Arthritis 1 item
  33. Thyroid Cancer 4item